Erratum Vol.7, No. 2.

In the article "Economic Impact of Antimicrobial Resistance," by John E. McGowan, Jr., an error occurred in the estimate in the first paragraph. The second sentence should read, "The Institute of Medicine estimates the annual cost of infections caused by antibiotic-resistant bacteria to be U.S. $4 to $5 billion" (1). We regret any confusion this error may have caused.

COPYRIGHT 2001 U.S. National Center for Infectious Diseases
No portion of this article can be reproduced without the express written permission from the copyright holder.

Reader Opinion

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:	correction to "Economic impact of antimicrobial resistance"
Author:	McGowan, John E.
Publication:	Emerging Infectious Diseases
Article Type:	Correction Notice
Date:	Jul 1, 2001
Words:	60
Previous Article:	Mycobacterium tuberculosis Beijing Genotype, Thailand--Reply to Dr. Prodinger.
Next Article:	Vulimiri Ramalingaswami (1921-2001).(Obituary)
Topics:	Drug resistance in microorganisms Economic aspects Microbial drug resistance Economic aspects

Related Articles
Economic Impact of Antimicrobial Resistance.
Building Communication Networks: International Network for the Study and Prevention of Emerging Antimicrobial Resistance.
Errata.(Vol. 6, No. 5 and Vol. 7, No. 1)(Correction Notice)
Surveillance for antimicrobial resistance in Croatia. (Synopsis).
Current status of antimicrobial resistance in Taiwan. (Synopsis).
A European study on the relationship between antimicrobial use and antimicrobial resistance. (Research).(Statistical Data Included)
The use of antimicrobials outside human medicine: information from the World Health Organization on the health consequences. (Technical Briefs).
An emptying quiver: antimicrobial drugs and resistance.(INTRODUCTION)
Antimicrobial resistance determinants and future control.(PERSPECTIVE)
Community prescribing and resistant Streptococcus pneumoniae.(RESEARCH)